These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32779407)

  • 21. High-frequency oscillatory ventilation versus synchronized intermittent mandatory ventilation plus pressure support in preterm infants with severe respiratory distress syndrome.
    Sun H; Cheng R; Kang W; Xiong H; Zhou C; Zhang Y; Wang X; Zhu C
    Respir Care; 2014 Feb; 59(2):159-69. PubMed ID: 23764865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term Effects of Intratracheal Budesonide and Surfactant for the Prevention of Bronchopulmonary Dysplasia: A Narrative Review.
    Nobile S; Di Sipio Morgia C; Hall M
    Am J Perinatol; 2024 May; 41(S 01):e1858-e1865. PubMed ID: 37279790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained lung inflation at birth via short binasal prong in very low birth weight preterm infants: A retrospective study.
    Buyuktiryaki M; Kanmaz HG; Okur N; Bezirganoglu H; Ozer Bekmez B; Simsek GK; Canpolat FE; Oguz SS; Tayman C
    Pediatr Pulmonol; 2018 Oct; 53(10):1407-1413. PubMed ID: 29999603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Physiological and Adrenal Effects of Budesonide Mixed with Surfactant in Large Observational Preterm Cohort Study.
    Becker SA; Kothe TB; Josephsen JB; Jackson K; Williams HL; Hillman NH
    Neonatology; 2022; 119(4):474-482. PubMed ID: 35598595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic versus Early Rescue Surfactant Treatment in Preterm Infants Born at Less than 30 Weeks Gestation or with Birth Weight Less than or Equal 1,250 Grams.
    Chun J; Sung SI; Ho YH; Kim J; Park GY; Yoon SA; Ahn SY; Chang YS; Park WS
    J Korean Med Sci; 2017 Aug; 32(8):1288-1294. PubMed ID: 28665065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study.
    Yeh TF; Lin HC; Chang CH; Wu TS; Su BH; Li TC; Pyati S; Tsai CH
    Pediatrics; 2008 May; 121(5):e1310-8. PubMed ID: 18426851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surfactant and budesonide for respiratory distress syndrome: an observational study.
    Kothe TB; Sadiq FH; Burleyson N; Williams HL; Anderson C; Hillman NH
    Pediatr Res; 2020 Apr; 87(5):940-945. PubMed ID: 31715622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy analysis of different pulmonary surfactants in premature infants with respiratory distress syndrome].
    Xu H; Xu P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):174-179. PubMed ID: 33729136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of minimally invasive pulmonary surfactant administration in preterm infants with neonatal respiratory distress syndrome: a multicenter clinical trial].
    Liu HQ; Tong XM; Han TY; Zhang H; Guo M; Zhang XF; Liu XJ; Zhang X; Zhang MT; Liu F; Bao LS; Zheng J; Tian XY; Gao Q; Zhang WX; Duan Y; Sun FF; Guo W; Li L; Xiao M; Liu WL; Jiang R
    Zhonghua Er Ke Za Zhi; 2020 May; 58(5):374-380. PubMed ID: 32392952
    [No Abstract]   [Full Text] [Related]  

  • 33. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; 1997(2):CD000511. PubMed ID: 10796380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome.
    Keszler M; Modanlou HD; Brudno DS; Clark FI; Cohen RS; Ryan RM; Kaneta MK; Davis JM
    Pediatrics; 1997 Oct; 100(4):593-9. PubMed ID: 9310511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
    Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of different inhaled corticosteroids for bronchopulmonary dysplasia prevention in preterm infants: A systematic review and meta-analysis.
    Zhang M; Zhang W; Liao H
    Respir Med Res; 2024 Jun; 85():101096. PubMed ID: 38744231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchopulmonary dysplasia in very low birth weight infants.
    Demirel N; Bas AY; Zenciroglu A
    Indian J Pediatr; 2009 Jul; 76(7):695-8. PubMed ID: 19381510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early neonatal outcomes of volume guaranteed ventilation in preterm infants with respiratory distress syndrome.
    Guven S; Bozdag S; Saner H; Cetinkaya M; Yazar AS; Erguven M
    J Matern Fetal Neonatal Med; 2013 Mar; 26(4):396-401. PubMed ID: 23039373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001079. PubMed ID: 10796410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A follow-up study of preterm infants given budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants.
    Kuo HT; Lin HC; Tsai CH; Chouc IC; Yeh TF
    J Pediatr; 2010 Apr; 156(4):537-41. PubMed ID: 20138301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.